Compare Align Technology, Inc. (ALGN) vs SOLAI Limited (SLAI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs SOLAI Limited — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while SOLAI Limited trades at $3.34 (market cap $15.52M). The key difference: Align Technology, Inc. is far larger — about 828.6× SOLAI Limited's market cap, and Align Technology, Inc. is trading nearer its 52-week high, SOLAI Limited nearer its low. Which is the better fit depends on your goals.
| ALGN | SLAI | |
|---|---|---|
Market Cap | $12.86B | $15.52M |
Sector | Health | Technology |
52-Week High | $207.19 | $30.66 |
52-Week Low | $124.88 | $2.74 |
Enterprise Value | $11.92B | $15.16M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
SLAI trades at $3.34, up 7.05% today, but technical indicators signal a bearish trend with support at $3. The company reported a net loss of $33.88M in 2025, with negative profit margins and ROE. Recent news includes a reverse stock split and a going-private proposal, while the sole analyst coverage is a Hold rating.
The outlook remains highly speculative due to persistent losses and NYSE listing concerns. Risks include financial instability and execution challenges in AI infrastructure. Upside depends on successful acquisitions and product launches, but the stock is suitable only for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About SOLAI Limited
SOLAI focuses on providing innovative AI-driven software solutions. The company leverages artificial intelligence to enhance digital experiences and optimize business processes for various industries.
Read more on SLAI →
